ISRCTN10909864
Completed
N/A
Extended cardiopulmonary resuscitation using a pediatric self-inflating bag in adult cardiac arrest patients reaching termination-of-resuscitation criteria – a prospective interventional study
Jawaharlal Institute of Post Graduate Medical Education and Research0 sites130 target enrollmentDecember 20, 2023
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Airway management during adult extended CPR using an adult inflating bag versus a pediatric self-inflating bag
- Sponsor
- Jawaharlal Institute of Post Graduate Medical Education and Research
- Enrollment
- 130
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Intubated adult (\> 18 years) cardiac arrest patients undergoing cardiopulmonary resuscitation in the Emergency Department
Exclusion Criteria
- •1\. Pregnant women
- •2\. Bleeding or secretions in the endotracheal tube
- •3\. Non\-availability of flow analyzer
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, Not Recruiting
N/A
CPR Training for parents of at risk newborCTRI/2020/10/028714DrShashidhar
Completed
N/A
Compression Only CardioPulmonary Resuscitation in telephone assisted bystandersCardiopulmonary resuscitationNot ApplicableISRCTN51784217Individual Sponsor (Austria)24
Completed
N/A
Arrest 8: maximizing cardiopulmonary resuscitation (CPR) during the use of the automatic external defibrillatorOut-of-hospital cardiac arrest (OHCA)Circulatory SystemCardiac arrestISRCTN72257677Academic Medical Center (AMC) (Netherlands)392
Not Yet Recruiting
N/A
A clinical audit on resuscitation outcome in teaching hospitalHealth Condition 1: O- Medical and SurgicalCTRI/2020/11/029095PSG IMSR
Active, Not Recruiting
Phase 1
CardioPulmonary resuscitation with Argon (CPAr) trialCardiac ArrestMedDRA version: 20.0Level: LLTClassification code 10019249Term: Heart arrestSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2018-003047-32-ITIRCCS- ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI50